Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.75 |
| ▸ | AHR | P35869 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.36 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1843312 | 0.86 | TSHR (1.00) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL10399643 | 0.86 | TSHR (0.71) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL11591961 | 0.83 | TSHR (0.68) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL11665761 | 0.81 | TSHR (0.65) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL29402881 | 0.78 | TSHR (0.61) | TSHRAHRTP53ALDH1A1RAD51 | |
| SCHEMBL980201 | 0.78 | TSHR (0.61) | TSHRAHRTP53ALDH1A1RAD51 | |
| SCHEMBL799541 | 0.78 | TSHR (0.61) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL5406314 | 0.78 | TSHR (0.68) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL11501810 | 0.78 | TSHR (0.60) | TSHRAHRTP53HSD17B10CYP3A4 | |
| SCHEMBL11867927 | 0.78 | TSHR (0.60) | TSHRAHRTP53HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070270618-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | MARHOLD ALBRECHT | 2007-11-22 | — | — | US | disclosed |
| US-7268260-B2 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-11 | — | — | US | disclosed |
| US-20060266985-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | MARHOLD ALBRECHT | 2006-11-30 | — | — | US | disclosed |
| US-7112704-B2 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | BAYER AKTIENGESELLSCHAFT (DE) | 2006-09-26 | — | — | US | disclosed |
| US-20050230669-A1 | coupling 4-halobenzotrichlorides in the presence of copper and tertiary amine solvents, to form chemical intermediates for liquid crystals, flameproofing, polyesters, polyethers or polycarbonates | LANXESS DEUTSCHLAND GMBH (DE) | 2005-10-20 | — | — | US | disclosed |
| US-6936739-B2 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | BAYER AKTIENGESELLSCHAFT (DE) | 2005-08-30 | — | — | US | disclosed |
| US-20030009060-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | LANXESS DEUTSCHLAND GMBH (DE) | 2003-01-09 | — | — | US | disclosed |
| EP-1262471-A2 | Fluorine-containing bisphenols, their preparation, intermediates towards their preparation, and their use | BAYER AG (DE) | 2002-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050230669-A1 | coupling 4-halobenzotrichlorides in the presence of copper and tertiary amine solvents, to form chemical intermediates for liquid crystals, flameproofing, polyesters, polyethers or polycarbonates | CYP4F2, CYP4F12, CYP4F3 | TSHR 431/4885AHR 124/4885TP53 3347/4885 |
| US-20060266985-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | CYP4F2, AFF4, CYP4F3 | TSHR 222/4885AHR 38/4885TP53 458/4885 |
| US-20070270618-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | CYP4F2, AFF4, CYP4F3 | TSHR 222/4885AHR 38/4885TP53 458/4885 |
| US-20030009060-A1 | Fluorine-containing bisphenols, their preparation, their precursors and intermediates, and use of the fluorine-containing bisphenols | CYP2F1, HNF4A, FLI1 | TSHR 219/4885AHR 28/4885TP53 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.